Biomarker Core
生物标志物核心
基本信息
- 批准号:10369039
- 负责人:
- 金额:$ 9.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAge-associated memory impairmentAged, 80 and overAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease related dementiaAlzheimer’s disease biomarkerAmyloid beta-ProteinApolipoprotein EAreaAwardBehavior monitoringBiological MarkersBloodBlood specimenClinicalCollaborationsDNADataDementiaDevelopmentDiseaseDisease ProgressionEducationElderlyFosteringFundingGeneticGenetic RiskGenotypeGoalsGrantGrowthHomeKnowledgeMeasurementMeasuresMissionMonitorNamesNeurodegenerative DisordersOmega-3 Fatty AcidsOregonPeptidesPeripheralPlasmaPractice GuidelinesProtocols documentationPublishingRNAReagentResearchResearch Peer ReviewResearch PersonnelResearch SupportSamplingSingle Nucleotide PolymorphismSiteSpecimenStandardizationStructureTechnologyTestingUnited States National Institutes of HealthWorkaging brainbasebiomarker developmentcohortcooperative studydata sharingexperienceextracellularimaging biomarkerimprovedinnovationmicroRNA biomarkersmild cognitive impairmentneuroimagingneuropathologynew technologynovelpre-clinicalprospectiverepositorysample collectiontau Proteinstau-1vascular factor
项目摘要
Project Summary: Biomarker Core
The Biomarker Core is aligned to support the overall goals of the OADRC: To provide a structure and forum to
foster and develop new and innovative research in brain aging and the dementias, and to facilitate
collaborative research, scientific interactions, and data sharing transfer with other Alzheimer’s Disease
Centers, the National Alzheimer’s Coordinating Center, the Alzheimer’s Disease Cooperative Study Unit, the
Alzheimer’s Consortium Treatment Consortium, the National Centralized Repository for Alzheimer’s Disease
and Related Dementias, and many other relevant outside research groups.
The mission of the OADRC’s Biomarker Core is to improve and maximize the quality and availability of
biomarker samples and information for research. It is organized to support current research, and to anticipate
future research requirements made possible by new knowledge and new technologies. The Specific Aims of
the Biomarker Core are as follows:
1) To obtain and make available for research, biomarker specimens (DNA, plasma, and CSF) from
OADRC subjects, including healthy control subjects, subjects with mild cognitive impairment (MCI), and
subjects with AD and other dementias.
2) To obtain and make available for research, biomarker data on OADRC subjects. This will include: a)
apolipoprotein E (ApoE) genotype on all subjects, b) single nucleotide polymorphism (SNP) profiles on
select cohorts, c) genetic risk scores on select cohorts, and d) CSF Abeta, tau, and ptau values for
OADRC subjects who donate CSF for research.
3) To foster collaborative research involving biomarkers and neurodegenerative disease. The areas of
emphasis for the OADRC have been described in the overview as (a) Preclinical dementia and activity
of disease emphasizing the oldest old; (b) Markers of meaningful change captured through studies of
peripheral biomarkers, neuroimaging and continuous in-home behavioral monitoring; (c)
Neuropathology of brain aging and late life dementia; (d) Novel testing of novel treatments; and (e)
Improving education and sharing knowledge about dementia. These areas will be priorities for the Core
to support in collaborative work. In addition, the OADRC recognizes a responsibility to support all NIH-
funded and comparably peer-reviewed research whenever possible.
项目摘要:生物标志物核心
生物标志物核心与支持OADRC的总体目标相一致:提供一个结构和论坛,
促进和发展脑老化和痴呆症方面的创新研究,并促进
协作研究,科学互动,以及与其他阿尔茨海默病患者的数据共享传输
中心,国家阿尔茨海默氏症协调中心,阿尔茨海默氏症合作研究单位,
阿尔茨海默氏症治疗联合会,国家阿尔茨海默氏症集中储存库
和相关的痴呆症,以及许多其他相关的外部研究小组。
OADRC的生物标志物核心的使命是提高和最大限度地提高生物标志物的质量和可用性,
生物标志物样本和研究信息。它的组织是为了支持当前的研究,并预测
新知识和新技术使未来的研究需求成为可能。的具体目标
生物标志物核心如下:
1)为了获得并提供用于研究的生物标志物标本(DNA、血浆和CSF),
OADRC受试者,包括健康对照受试者、轻度认知障碍(MCI)受试者,以及
患有AD和其他痴呆的受试者。
2)获取并提供OADRC受试者的生物标志物数据用于研究。这将包括:(a)
B)所有受试者的载脂蛋白E(ApoE)基因型,
选择队列,c)选择队列的遗传风险评分,和d)CSF Abeta、tau和ptau值,
捐献CSF用于研究的OADRC受试者。
3)促进涉及生物标志物和神经退行性疾病的合作研究。领域
OADRC的重点已在概述中描述为(a)临床前痴呆和活动
(B)通过对以下疾病的研究获得的有意义的变化的标志:
外周生物标志物、神经成像和连续的家庭行为监测;(c)
脑老化和老年痴呆症的神经病理学;(d)新疗法的新测试;和(e)
改善教育和分享有关痴呆症的知识。这些领域将是核心小组的优先事项。
支持协同工作。此外,OADRC认识到有责任支持所有NIH-
在可能的情况下资助和审查研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH F QUINN其他文献
JOSEPH F QUINN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH F QUINN', 18)}}的其他基金
ShEEP Request for Seahorse Analyzer for Measuring Mitochondrial Respiration
ShEEP 请求使用 Seahorse 分析仪来测量线粒体呼吸
- 批准号:
9908873 - 财政年份:2019
- 资助金额:
$ 9.73万 - 项目类别:
A novel estrogen modulator for the treatment of Alzheimer's disease
一种用于治疗阿尔茨海默病的新型雌激素调节剂
- 批准号:
9898288 - 财政年份:2018
- 资助金额:
$ 9.73万 - 项目类别:
A novel estrogen modulator for the treatment of Alzheimer's disease
一种用于治疗阿尔茨海默病的新型雌激素调节剂
- 批准号:
10158406 - 财政年份:2018
- 资助金额:
$ 9.73万 - 项目类别:
Biological signatures of the cognitive effects of Centella asiatica
积雪草认知影响的生物学特征
- 批准号:
9563219 - 财政年份:2017
- 资助金额:
$ 9.73万 - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8634332 - 财政年份:2014
- 资助金额:
$ 9.73万 - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
9339519 - 财政年份:2014
- 资助金额:
$ 9.73万 - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8974327 - 财政年份:2014
- 资助金额:
$ 9.73万 - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8815001 - 财政年份:2014
- 资助金额:
$ 9.73万 - 项目类别:
相似海外基金
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7606738 - 财政年份:2007
- 资助金额:
$ 9.73万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7717960 - 财政年份:2007
- 资助金额:
$ 9.73万 - 项目类别:
THE GENETICS AND FUNCTIONAL NEUROANATOMY OF AGE-ASSOCIATED MEMORY IMPAIRMENT
年龄相关记忆障碍的遗传学和功能神经解剖学
- 批准号:
7205360 - 财政年份:2004
- 资助金额:
$ 9.73万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6305687 - 财政年份:1999
- 资助金额:
$ 9.73万 - 项目类别:
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6115572 - 财政年份:1998
- 资助金额:
$ 9.73万 - 项目类别:
A study on the biological features of age-associated memory impairment (AAMI).
年龄相关记忆障碍(AAMI)生物学特征的研究。
- 批准号:
09671003 - 财政年份:1997
- 资助金额:
$ 9.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C).
CITICOLINE AND AGE ASSOCIATED MEMORY IMPAIRMENT
胞二磷胆碱与年龄相关的记忆障碍
- 批准号:
6276806 - 财政年份:1997
- 资助金额:
$ 9.73万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386469 - 财政年份:1990
- 资助金额:
$ 9.73万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
3386468 - 财政年份:1990
- 资助金额:
$ 9.73万 - 项目类别:
AGE-ASSOCIATED MEMORY IMPAIRMENT: COMMUNITY-BASED STUDY
与年龄相关的记忆障碍:基于社区的研究
- 批准号:
2247160 - 财政年份:1990
- 资助金额:
$ 9.73万 - 项目类别: